000 01749 a2200421 4500
005 20250517151445.0
264 0 _c20180223
008 201802s 0 0 eng d
022 _a1969-6213
024 7 _a10.4244/EIJ-D-15-00259
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGeis, Nicolas A
245 0 0 _aFeasibility and safety of vitamin K antagonist monotherapy in atrial fibrillation patients undergoing transcatheter aortic valve implantation.
_h[electronic resource]
260 _bEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
_cApr 2017
300 _a2058-2066 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAnticoagulants
_xtherapeutic use
650 0 4 _aAtrial Fibrillation
_xcomplications
650 0 4 _aFeasibility Studies
650 0 4 _aFemale
650 0 4 _aGermany
_xepidemiology
650 0 4 _aHemorrhage
_xchemically induced
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPhenprocoumon
_xtherapeutic use
650 0 4 _aPostoperative Complications
_xetiology
650 0 4 _aThromboembolism
_xprevention & control
650 0 4 _aTranscatheter Aortic Valve Replacement
700 1 _aKiriakou, Christina
700 1 _aChorianopoulos, Emmanuel
700 1 _aPleger, Sven T
700 1 _aKatus, Hugo A
700 1 _aBekeredjian, Raffi
773 0 _tEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
_gvol. 12
_gno. 17
_gp. 2058-2066
856 4 0 _uhttps://doi.org/10.4244/EIJ-D-15-00259
_zAvailable from publisher's website
999 _c27104688
_d27104688